Puma Biotechnology (PBYI) Amortization of Deferred Charges (2015)

Puma Biotechnology (PBYI) reported Amortization of Deferred Charges of $179000.0 for Q1 2015.

Puma Biotechnology (PBYI) Amortization of Deferred Charges (2015) Analysis & Trends

Puma Biotechnology has reported Amortization of Deferred Charges for 1 years, with the latest figure at $179000.0 in Q1 2015.

For the quarter ending Q1 2015, Amortization of Deferred Charges changed N/A year-over-year to $179000.0; the trailing twelve-month figure through Dec 2015 stood at $179000.0 (changed N/A YoY), and the FY2016 full-year result was $3.0 million, up 1574.3% from the prior year.
Amortization of Deferred Charges for Q1 2015 stood at $179000.0.
The five-year high for Amortization of Deferred Charges was $179000.0 in Q1 2015, with the low at $179000.0 in Q1 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Puma Biotechnology	384.39 Mn	282.84 Mn	34.39 Mn

Download Data

Date	Value
Mar 31, 2015	179,000.00
Mar 31, 2015	179,000.00